Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening

On this page
Share

The histone acetyltransferases (HATs) in mammals include GCN5 N-acetyltransferases, the MOZ, YBF2, SAS2, and TIP60 proteins, and the orphan HATs. The males absent on the first (MOF) is mainly related to acetylation of histone H4 Lys16 and has influence on downstream genes expression. However, the only inhibitor MG149 presented low activity against MOF. Besides, there was no high throughput screening platform on MOF, which limited the inhibitor discovery and functional study. In our study, we set up a high throughput screening platform based on amplified luminescent proximity homogeneous assay (ALPHA), which led us to a moderate inhibitor DC_M01. By chemical modification, we found DC_M01_7, which was the analog of DC_M01 with an IC50 value of 6 μM. DC_M01_7 significantly inhibited HCT116 cells proliferation and could also inhibit histone 4 lysine 16 acetylation in HCT116 cells. To sum up, our work will probably assist the further development of more potent MOF inhibitors and the functional study of hMOF.

Explore other resources

Case Studies

See how programs moved from early target work to IND. Real timelines, real decisions, and the science that got partners there.

Resource Library

Peer-reviewed publications, press releases, and interviews with our scientists. More than 20 years of discovery, in one place.

Insights

Perspectives from the people running programs every day, plus news on the partnerships and capabilities shaping the work.

Events

Webinars, conferences, and workshops throughout the year. Find out where our teams will be and what they’ll be presenting.

START YOUR JOURNEY
Phase
Modality
Therapeutic Area